Cite
A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus
MLA
Tavel, Jorge A., et al. “A Randomized, Double-Blinded, Placebo-Controlled Trial of Intermittent Administration of Interleukin-2 and Prednisone in Subjects Infected with Human Immunodeficiency Virus.” Journal of Infectious Diseases, vol. 188, no. 4, Aug. 2003, p. 531. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.107996930&authtype=sso&custid=ns315887.
APA
Tavel, J. A., Sereti, I., Walker, R. E., Hahn, B., Kovacs, J. A., Jagannatha, S., Davey, R. T., Jr., Falloon, J., Polis, M. A., Masur, H., Metcalf, J. A., Stevens, R., Rupert, A., Baseler, M., & Lane, H. C. (2003, August 15). A randomized, double-blinded, placebo-controlled trial of intermittent administration of interleukin-2 and prednisone in subjects infected with human immunodeficiency virus. Journal of Infectious Diseases, 188(4), 531.
Chicago
Tavel, Jorge A., Irini Sereti, Robert E. Walker, Barbara Hahn, Joseph A. Kovacs, Shyla Jagannatha, Richard T. Davey Jr., et al. 2003. “A Randomized, Double-Blinded, Placebo-Controlled Trial of Intermittent Administration of Interleukin-2 and Prednisone in Subjects Infected with Human Immunodeficiency Virus.” Journal of Infectious Diseases, August 15. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsggo&AN=edsgcl.107996930&authtype=sso&custid=ns315887.